Mesenchymal stem cell-derived exosomes have altered microRNA profiles and induce osteogenic differentiation depending on the stage of differentiation

PLoS One. 2018 Feb 15;13(2):e0193059. doi: 10.1371/journal.pone.0193059. eCollection 2018.

Abstract

Human mesenchymal stem cell (hMSC)-derived exosomes have shown regenerative effects, but their role in osteogenesis and the underlying mechanism are yet to be determined. In this study, we examined the time-course secretion of exosomes by hMSCs during the entire process of osteogenic differentiation. Exosomes derived from hMSCs in various stages of osteogenic differentiation committed homotypic cells to differentiate towards osteogenic lineage, but only exosomes from late stages of osteogenic differentiation induced extracellular matrix mineralisation. Exosomes from expansion and early and late stages of osteogenic differentiation were internalised by a subpopulation of hMSCs. MicroRNA profiling revealed a set of differentially expressed exosomal microRNAs from the late stage of osteogenic differentiation, which were osteogenesis related. Target prediction demonstrated that these microRNAs enriched pathways involved in regulation of osteogenic differentiation and general mechanisms how exosomes exert their functions, such as "Wnt signalling pathway" and "endocytosis". Taken together, the results show that MSCs secrete exosomes with different biological properties depending on differentiation stage of their parent cells. The exosomal cargo transferred from MSCs in the late stage of differentiation induces osteogenic differentiation and mineralisation. Moreover, it is suggested that the regulatory effect on osteogenesis by exosomes is at least partly exerted by exosomal microRNA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaline Phosphatase / metabolism
  • Calcium / metabolism
  • Cell Differentiation / genetics
  • Cells, Cultured
  • Exosomes / genetics*
  • Exosomes / metabolism
  • Exosomes / ultrastructure
  • Gene Expression Profiling
  • Humans
  • Mesenchymal Stem Cells / cytology*
  • Mesenchymal Stem Cells / metabolism*
  • MicroRNAs / genetics*
  • MicroRNAs / metabolism
  • Microscopy, Electron, Transmission
  • Osteogenesis / genetics*
  • Signal Transduction / genetics

Substances

  • MicroRNAs
  • Alkaline Phosphatase
  • Calcium

Grants and funding

The study was supported by the BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy (www.biomatcell.org.gu.ge), the Västra Götaland Region (www.vgregion.se), the Swedish Research Council (www.vr.se), K2015-52X-09495-28-4, (PT), the LUA/ALF Research Grant “Optimization of osseointegration for treatment of transfemoral amputees” (http://www.researchweb.org/is/alfgbg), ALFGBG-448851 (PT), the IngaBritt and Arne Lundberg Foundation (http://www.lundbergsstiftelsen.se), 2014-0049 (PT), Stiftelsen Hjalmar Svenssons Forskningsfond (https://stiftelsemedel.se, HJSV2014073 (XW), HJSV2013030 (XW), HJSV201341 (KE), HJSV2014059 (KE) Adlerbertska forskningsstiftelsen (www.adlerbertska.se) E 2015/78 (KE)), Magnus Bergvalls stiftelse (www.magnusbergvallsstiftelse.nu) 20140115 (KE), the Vilhelm and Martina Lundgren Vetenskapsfond (http://www.wmlundgren.se) 107/2014 (PT) and the Area of Advance Materials of Chalmers and GU Biomaterials within the Strategic Research Area initiative launched by the Swedish Government (www.chalmers.se/en/areas-of-advance/materials) (PT). The grant providers were not involved in the study design, data acquisition, interpretation, writing and submission of the article. The authors confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.